Trial to Assess Effect of Raltegravir on HTLV-1 Proviral Load

NCT01620736 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The clinical trial did not receive any funding.

Conditions

Human T-cell Leukemia Virus Type 1 Infection

Interventions

DRUG: Raltegravir

Sponsor

Washington University School of Medicine

Collaborators

[object Object]